Loading…
History for this window is not loaded yet.
HRTS and TDNA share 17.0% of their holdings.
| Side by side |
|---|
| HRTS |
|---|
| TDNA |
|---|
| RFLR |
|---|
| Strategy | Unsorted | Sectors · Health care | Defined Outcome · Hedged equity |
| Expense ratio | 0.99% | 0.55% | 0.89% |
| Cost per year on $10k | $99 | $55 | $89 |
| Trailing 12-mo yield | 1.22% | 0.00% | 0.65% |
| Income per year on $10k | $122 | $0 | $65 |
| YTD | +9.9% | — | +12.5% |
| 1 year | +20.9% | — | +14.0% |
| 3 years · per year | — | — | — |
| 5 years · per year | — | — | — |
| Worst drop · 1Y | −11.0% | — | −7.1% |
| Volatility · 1Y | 16.6% | — | 11.8% |
| Holdings | 47 | 0 | 831 |
| Assets | $58M | $11M | $95M |
| Leverage | None | None | None |
| Since | 2023 | 2026 | 2024 |
Highlighted = best in the row. Returns include dividends.